| ID: | 62 | |
|---|---|---|
| Name: | Compound 62 | |
| Description: | Original numeration in publication: 17 | |
| Labels: | Training_set, Pyridines | |
| CAS: | ||
| InChi Code: | InChI=1S/C17H11BrN4O/c18-14-7-3-1-5-11(14)10-20-22-17-13(9-19)16(23)12-6-2-4-8-15(12)21-17/h1-8,10,13H,(H,21,22)/b20-10+/t13-/m0/s1 |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.72 |
Saleh, N. M.; Abdel-Rahman, A. A.-H.; Omar, A. M. a. K., M. M.; El-Adl, K. Pyridine-derived VEGFR-2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking. Arch. Pharm. (Weinheim) 2021, 354, e2100085. https://doi.org/10.1002/ardp.202100085 |
| 7.19815 |
Eq1: VEGFR-2 inhibition (Data used to train model) |